Error: Could not add to watchlist. X

Primus Therapeutics Inc

+ Watchlist
PRTH/U:US
NASDAQ CM
Pending Listing
PRTH/U:US is pending Listing
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Primus Therapeutics Inc. a start-up company with no revenues. The Company plans to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation.
ADDRESS
23 Orchard Road
Suite 105
Skillman, NJ 08558
United States
PHONE
1-800-903-4131
  • Joseph A Falsetti "Joe"
    Chairman
  • Dennis M O'Donnell
    President/CEO/Co-Founder
  • Mark I Massad
    Chief Financial Officer
Show More